| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 10/22/2008 | CN101291911A Crystals of laquinimod sodium, and process for the manufacture thereof |
| 10/22/2008 | CN101289424A Quinate compounds with high anti-coccidian activity and growth-promoting effect |
| 10/22/2008 | CN101289423A 7-chlorine -4-(1- piperazinyl)chinoline and applications thereof in preparation of anti-malaria medicaments |
| 10/22/2008 | CN100427480C Process for preparing argatroban hydrate |
| 10/22/2008 | CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/21/2008 | US7439364 Process for the synthesis of derivatives of halo-[2,3-F] quinoline |
| 10/21/2008 | US7439363 Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors |
| 10/21/2008 | US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 10/21/2008 | US7439244 e.g. 8-(4-(4-Fluorobenzyl)-piperazin-1-yl)-3-phenylsulfonylquinoline; serotonin receptor modulator; antidepressant, anxiolytic agent, cognition activator; schizophrenia, obesity, Alzheimer's disease |
| 10/21/2008 | US7439243 Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders |
| 10/21/2008 | US7439242 PPARγ modulators |
| 10/21/2008 | CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 10/16/2008 | WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 10/16/2008 | WO2008123469A1 Six-membered amide compound and use thereof |
| 10/16/2008 | WO2008123207A1 Ornithine derivative |
| 10/16/2008 | WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 10/16/2008 | WO2008122784A1 Quinolines and their therapeutic use |
| 10/16/2008 | WO2008122620A1 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerisation |
| 10/16/2008 | WO2008122618A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
| 10/16/2008 | WO2008091752A3 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 10/16/2008 | WO2008011513B1 Compounds and methods of modulating angiogenesis |
| 10/16/2008 | US20080255359 Novel Chemical Process For the Synthesis of Quinoline Compounds |
| 10/16/2008 | US20080255345 IRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof |
| 10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255192 Methods and Compositions for Selectin Inhibition |
| 10/16/2008 | US20080255190 Bactericides for grampositive and gramnegative infections |
| 10/16/2008 | US20080255189 using an thiourea compound or carbonyl thiourea compound; therapy for drug resistant infections |
| 10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
| 10/16/2008 | US20080255117 Sulfonyltryptophanols |
| 10/16/2008 | US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance |
| 10/16/2008 | US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/16/2008 | US20080255068 Tetrahydroquinoline compound; cardiovascular disorders; arteriosclerosis |
| 10/16/2008 | US20080255042 CaSR Antagonist |
| 10/16/2008 | US20080254318 Charge generating and charge transfer compounds;applying carbazole compound; reducing drive voltage ; emission efficiency; accuracy |
| 10/16/2008 | CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 10/16/2008 | CA2681861A1 Ornithine derivative |
| 10/16/2008 | CA2680682A1 Quinolines and their therapeutic use |
| 10/15/2008 | EP1980564A1 Antibiotics containing borinic acid complexes and methods of use |
| 10/15/2008 | EP1979367A2 Quinolin-4-one derivatives as modulators of abc transporters |
| 10/15/2008 | EP1978961A2 Tetralone-based monoamine reuptake inhibitors |
| 10/15/2008 | EP1978960A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-ý(2s)-1-hydroxy-3-methylbutan-2-yl¨-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 10/15/2008 | EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 10/15/2008 | CN101287727A Novel high affinity quinoline-based kinase ligands |
| 10/15/2008 | CN101287709A 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 10/14/2008 | US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/14/2008 | US7435815 Sulfonylamino-acetic acid derivatives |
| 10/14/2008 | US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/09/2008 | WO2008121817A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 10/09/2008 | WO2008121805A1 Methods and compositions for selectin inhibition |
| 10/09/2008 | WO2008119917A1 Quinoline derivatives as crth2 receptor ligands |
| 10/09/2008 | WO2008119771A2 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors |
| 10/09/2008 | WO2008083635B1 A method for the preparation of montelukast |
| 10/09/2008 | WO2008064342A3 Pde10 inhibitors and related compositions and methods |
| 10/09/2008 | WO2008024922A3 8-hydroxyquinoline compounds and methods thereof |
| 10/09/2008 | US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease |
| 10/09/2008 | US20080249130 Oral dosage forms; antiproliferatives, anticholesterol agents; lipid metabolic disorders; myocardial infarction, stroke, restenosis, atherosclerosis |
| 10/09/2008 | US20080249110 Novel Substituted 3-Sulfur Indoles |
| 10/09/2008 | US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders |
| 10/09/2008 | US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide |
| 10/09/2008 | CA2682183A1 Methods and compositions for selectin inhibition |
| 10/09/2008 | CA2681757A1 Methods and compositions for selectin inhibition |
| 10/09/2008 | CA2680636A1 Quinoline derivatives as crth2 receptor ligands |
| 10/08/2008 | EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 10/08/2008 | EP1922135A4 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 10/08/2008 | EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 10/08/2008 | EP1341785B1 Hydrolysis of r(r*,r*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 10/08/2008 | CN101279983A 抗肿瘤联合药物 Joint anti-tumor drugs |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432388 Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity |
| 10/07/2008 | US7432377 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432282 3-{4-[(5-bromopyridin-3-ylmethyl)amino]butyl}-1H-indole-5-carbonitrile; neuroleptics and/or antihypertensives; bioavailability; absorbability |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/02/2008 | WO2008116308A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/02/2008 | WO2008059518A3 Process for preparing crystalline aripiprazole |
| 10/02/2008 | WO2007120621A3 Nonel 1,2,3,4-tetrahydroquinoline derivatives |
| 10/02/2008 | US20080242700 Methods and Compositions for Selectin Inhibition |
| 10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
| 10/02/2008 | DE102007016139A1 Verfahren zur regioselektiven Oxygenierung von N-Heterozyklen Method for the regioselective oxygenation of N-heterocycles |
| 10/02/2008 | CA2681771A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/01/2008 | EP1974212A1 Compounds useful in cftr assays and methods therewith |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | EP1274686B1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl proprionic acid |
| 10/01/2008 | CN101277935A Methods of preparing anhydrous aripiprazole form ii |
| 10/01/2008 | CN101277696A Quinoline derivatives as antibacterial agents |
| 10/01/2008 | CN101277695A Quinoline derivatives as antibacterial agents |
| 10/01/2008 | CN100422155C Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 10/01/2008 | CN100422154C Method for preparing 3-methyl quinolines-8-sulfochlorides |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7429666 Pyridine analogs as C5a antagonists |
| 09/30/2008 | US7429665 phosphodiesterase (PDE) inhibitors; 2-[4-(4-Pyridin-4-yl-2H-pyrazol-3-yl)-phenoxymethyl]-quinoline; for treating central nervous system disorders, neurodegenerative and psychiatric disorders |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429585 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 09/30/2008 | CA2381001C Carbamate derivative and agricultural/horticultural fungicide |
| 09/25/2008 | WO2008115140A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | US20080234484 Method for making tris (8-hydroxyquinoline) nano-crystal |
| 09/25/2008 | US20080234318 5,6,7,8-tetrahydro-8-quinolinamines as chemokine receptor CXCR4 antagonists such as N-{[3-[(Dimethylamino)methyl]-5-(4-methyl-1-piperazinyl)imidazo[1,2-a]pyridin-2-yl]methyl}-N-methyl-5,6,7,8-tetrahydro-8-quinolinamine; HIV infection, rheumatoid arthritis; antiinflammatory, anticarcinogenic agent |